Measuring potential cost and life savings of low cost biogeneric erythropoeitin among chronic dialysis patients

Low Cost Biogeneric Epoetin study

General Information

Research Type

Clinical

Description

Prospective study of epoietin utilisation, haemoglobin outcomes and survival of dialysis patients in Malaysia from 1997 to 2005. Assuming constant funding for epoietin, the study will estimate the increase in mean epoietin dose should its cost decrease with the introduction of low cost epoietin. A natural logarithmic regression model will be used to approximate the pharmacodynamics of epoietin. Mortality impact of higher haemoglobin will be estimated by a parametric Weibull regression model.

Study Information

RMK Priority Area

Research Level

Research Keyword

Anaemia, Dialysis, Generic substitution, Erythropoietin, Cost saving

Inclusion & Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Study Timeline

Expected / Actual Date Study Starts - First Enrolment of subject / Collecting data

May, 11 2006

Expected / Actual Date Study Completed

Expected / Actual Duration of Study Enrollment / Data Collection